Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Medico Intercontinental Ltd - 539938 - Compliance Under Reg. 23 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Dear Sir/Madam, As per the provisions of 15(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('LODR Regulations'), the compliances with corporate governance provisions as specified in Regulations 17 to 27 are applicable to the Company only if it's paid up Capital exceeds Rs. 10 Crores and if Net worth is above Rs. 25 Crores. As on 30th September, 2019, the paid up share capital of the company is Rs. 3,24,90,000/- (Rupees Three Crores Twenty-Four Lakhs Ninety Thousand only) which does not exceed Rs. 10 Crores limit and the Net Worth of the Company is Rs. 4,58,13,710/- (Rupees Four crores Fifty eight Lakhs Thirteen Thousand Seven hundred and ten only) which does not cross Rs. 25 Crores. Hence, the compliance of provisions of Regulations 17 to 27 of SEBI (LODR) Regulations are not applicable to the Company. In light of the above, the Company do not fall under the ambit of regulation 23 (9) of SEBI (LODR) Regulations, 2015. Kindly take the same on record.
20-11-2019
Bigul

Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Dear Sir/ Madam, We hereby wish to inform you that the Unaudited financial results (Standalone & Consolidated) for the quarter and half year ended on 30th September, 2019 were approved at the meeting of Board of Directors held on 14th November, 2019. In continuation to the same, the newspaper clipping duly published in English Newspaper (All Edition) and Marathi Newspaper (Mumbai Edition) dated 14th November, 2019 is enclosed herewith. This is for your information and records.
15-11-2019
Bigul

Medico Intercontinental Ltd - 539938 - Results - Quarter Ended On 30 September, 2019.

 Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., November 14, 2019, inter alia, considered and approved: 1. Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on September 30, 2019 along with Limited Review report issued by M/s. V Goswami & Co, Statutory Auditors of the Company and Statement of Assets and Liabilities and Cash Flow Statement for the half year ended on September 30, 2019. 2. Re-Appointment of M/s. MJV & Co, Chartered Accountants, Ahmedabad as an Internal Auditor of the Company for the F.Y. 2019-20.
14-11-2019
Bigul

Medico Intercontinental Ltd - 539938 - Outcome Of Board Meeting And Compliances Of Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015.

 Dear Sir/Ma'am, Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., November 14, 2019, inter alia, considered and approved: Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on September 30, 2019 along with Limited Review report issued by M/s. V Goswami & Co, Statutory Auditors of the Company and Statement of Assets and Liabilities and Cash Flow Statement for the half year ended on September 30, 2019. Re-Appointment of M/s. MJV & Co, Chartered Accountants, Ahmedabad as an Internal Auditor of the Company for the F.Y. 2019-20.
14-11-2019
Bigul

Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Dear Sir/Ma'am, Pursuant to Regulation 29 of SEBI (LODR) Regulations, 2015, we hereby inform you that meeting of Board of Directors is scheduled to be held on 14th November, 2019 to inter-alia consider, approve and take on record the unaudited financial results (Standalone & Consolidated) along with Limited review report for the quarter and half year ended on 30th September, 2019 and Statement of Assets and Liabilities for the half year ended on 30th September, 2019. In continuation to the same, the newspaper clipping duly published in English Newspaper (All edition) and Marathi Newspaper (Mumbai Edition) dated 7th November, 2019 is enclosed herewith. This is for your information and records.
07-11-2019
Bigul

Medico Intercontinental Ltd - 539938 - Board Meeting Intimation for Intimation Of Board Meeting In Compliance Of Regulation 29, 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve With reference to the captioned subject, we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 14th November, 2019 at the administrative Office of the Company situated at 501, 5th Floor, Aditraj Arcade, Near Hetvi Tower, 100 ft. Road, Satellite, Ahmedabad - 380015, to inter alia consider, approve and take on record the unaudited Financial Results (Standalone and Consolidated) along with limited review report for quarter and half year ended 30th September, 2019 and Statement of Assets and Liabilities for the half year ended on 30th September, 2019 and any other business items as per agenda circulated. You are requested to kindly take the same on your record.
06-11-2019
Bigul

Medico Intercontinental Ltd - 539938 - Compliance Certificate By PCS As Per Reg. 40(9) Of SEBI (LODR) Regulations, 2018.

 Subject: Submission of Compliance Certificate pursuant to Regulation 40(9) and 40(10) of the SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015 for the Half Year ended 30th September, 2019. Dear Sir/Ma'am, We are herewith enclosing Compliance Certificate, pursuant to Regulation 40(9) of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, issued by a Practicing Company Secretary for the Half Year ended 30th September, 2019. Kindly take the above on your records.
16-10-2019
Bigul

Medico Intercontinental Ltd - 539938 - Compliance Certificate For The Half Year Ended On 30.09.2019

 Dear Sir/Madam, In terms of Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended on 30th September, 2019, we hereby certify that all activities in relation to both physical and electronic share transfer facilities during the period 1st April, 2019 to 30th September, 2019 are maintained by company's registrar and share transfer agent Purva Sharegistry (India) Private Limited having registered office at 9, Shiv Shakti Industrial Estate, J.R. Boricha Marg, Opp Lower Parel (East), Mumbai - 400011 registered with Securities and Exchange Board of India bearing No. INR 000001112.
14-10-2019
Bigul

Medico Intercontinental Ltd - 539938 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Dear Sir/ Madam, We are herewith enclosing the Confirmation Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th September, 2019. Kindly take the above on your record.
14-10-2019
Bigul

Medico Intercontinental Ltd - 539938 - Shareholding for the Period Ended September 30, 2019

 Medico Intercontinental Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here
11-10-2019
Next Page
Close

Let's Open Free Demat Account